Purple Biotech Balance Sheet (2014-2026)

Reported Financials

Purple Biotech Quarterly Balance Sheet

Periods 36 quarters

Latest Jun 2026

Purple Biotech reported total assets of $14.17M and total liabilities of $1.95M for the quarter ended Jun 2026, down 58.8% year over year. This balance sheet covers 36 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	9.12M	10.89M	23.54M	14.01M	11.07M	15.03M	21.88M	17.20M	15.10M	14.49M	9.98M	6.52M	5.44M	7.40M	5.77M	4.74M	9.59M	8.72M	5.57M	5.24M
Receivables - NetNet Receivables	0.50M					0.43M
Receivables - OtherOther Receivables										0.00M				0.00M
Receivables	0.50M					0.43M
Prepaid Assets	1.13M	1.27M	2.35M	1.43M	1.22M	1.14M	1.29M	0.98M	0.63M	0.38M	0.55M	0.47M	0.64M	0.38M	0.43M	0.39M	0.32M	0.29M	0.35M	0.48M
Current Assets	47.20M	48.47M	41.90M	37.45M	34.31M	33.26M	24.41M	19.38M	16.72M	15.79M	11.40M	7.86M	6.94M	8.91M	7.51M	6.31M	10.77M	9.87M	6.78M	6.59M
Non-Current Assets
Property, Plant & Equipment (Net)	0.27M	21.73M	0.29M	0.24M	0.22M	21.37M	0.20M	0.18M	0.16M	28.51M	0.14M	0.12M	0.12M	28.13M	0.11M	0.14M	0.12M	0.12M	0.12M	0.12M
Long-Term Investments		0.19M	-1.13M	-0.29M	0.19M	0.43M	0.39M	0.35M	0.22M	0.07M	-0.21M	-0.16M	-0.02M	0.28M	0.47M	0.33M	-0.14M		-0.08M	-0.21M
Intangibles	20.48M	20.48M	20.68M	20.68M	20.68M	-0.20M	28.04M	28.04M	28.04M	28.04M	28.04M	27.84M	27.84M	27.84M	27.84M	27.84M	27.84M	7.36M	7.36M	7.36M
Goodwill & Intangibles	20.48M	20.48M	20.68M	20.68M	20.68M	20.68M	28.04M	28.04M	28.04M	28.04M	28.04M	27.84M	27.84M	27.84M	27.84M	27.84M	27.84M	7.36M	7.36M	7.36M
Other Non-Current Assets	5.02M	0.16M	2.66M	24.29M	24.24M	0.01M	28.67M	28.61M	28.55M	0.01M	28.46M	28.20M	28.17M	0.01M	28.08M	28.07M		7.71M	7.64M	7.58M
Non-Current Assets	26.43M	21.73M	24.39M	24.29M	24.24M	21.37M	28.67M	28.61M	28.55M	28.51M	28.46M	28.20M	28.17M	28.13M	28.08M	28.07M	28.29M	7.71M	7.64M	7.58M
Assets	73.63M	70.20M	66.29M	61.74M	58.54M	54.62M	53.08M	48.00M	45.27M	44.30M	39.86M	36.06M	35.10M	37.04M	35.59M	34.38M	39.06M	17.57M	14.42M	14.17M
Liabilities
Current Liabilities
Accounts Payables	2.08M	1.47M	1.65M	1.23M	2.77M	2.13M	2.45M	1.57M	2.59M	3.53M	3.48M	3.04M	1.91M	1.46M	0.87M	0.67M	0.60M	2.07M	0.84M	0.49M
Notes Payables
Payables	2.08M	1.47M	1.65M	1.23M	2.77M	2.13M	2.45M	1.57M	2.59M	3.53M	3.48M	3.04M	1.91M	1.46M	0.87M	0.67M	0.60M	2.07M	0.84M	0.49M
Accumulated Expenses	-0.86M	1.53M		-0.86M	-0.86M	3.60M				2.52M
Other Accumulated Expenses	1.14M	2.58M	5.34M	3.97M	2.98M	4.73M	2.98M	3.12M	3.45M	3.46M	2.80M	2.15M	1.80M	1.20M	1.34M	1.15M	1.17M	1.37M	1.67M	0.93M
Short term Debt
Current Leases	0.20M	0.20M	0.20M	0.20M	0.19M	0.19M	0.19M	0.18M	0.18M	0.19M	0.19M	0.18M	0.18M	0.18M	0.14M	0.10M	0.21M	0.24M	0.18M
Total Current Liabilities	3.43M	4.25M	7.19M	5.39M	5.93M	7.06M	5.62M	4.88M	6.22M	9.70M	8.51M	6.47M	5.46M	3.99M	2.76M	2.19M	6.06M	7.75M	4.59M	1.78M
Non-Current Liabilities
Pension	0.27M	0.29M	0.29M	0.29M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.16M	0.16M	0.17M
Minority Interest	0.31M	0.28M	0.26M	0.24M	0.22M	0.19M	0.16M	0.14M	0.12M	0.09M	0.07M	0.06M	0.06M	0.05M	0.05M	0.04M	0.04M	-0.06M	-0.06M	-0.06M
Operating Leases	0.56M	0.55M	0.49M	0.40M	0.36M	0.32M	0.28M	0.24M	0.19M	0.16M	0.12M	0.08M	0.04M	0.18M			0.05M	0.24M		0.13M
Other Non-Current Liabilities										2.52M	2.05M	1.10M	1.56M	1.15M	0.41M	0.27M	4.07M	4.07M	1.90M	0.23M
Total Non-Current Liabilities	0.83M	0.84M	0.79M	0.69M	0.50M	0.47M	0.42M	0.38M	0.33M	0.30M	0.26M	0.22M	0.18M	0.14M	0.14M	0.14M	0.19M	0.16M	0.16M	0.17M
Total Liabilities	4.25M	5.09M	7.97M	6.08M	6.43M	7.52M	6.04M	5.25M	6.55M	10.01M	8.77M	6.69M	5.64M	4.13M	2.90M	2.33M	6.25M	7.91M	4.75M	1.95M
Shareholder's Equity
Total Debt
Common Equity	69.37M	65.11M	58.32M	55.66M	52.11M	47.10M	47.05M	42.74M	38.72M	34.30M	31.09M	29.38M	29.47M	32.91M	32.70M	32.05M	32.81M	9.66M	9.66M	12.21M
Liabilities and Shareholders Equity	73.63M	70.20M	66.29M	61.74M	58.54M	54.62M	53.08M	48.00M	45.27M	44.30M	39.86M	36.06M	35.10M	37.04M	35.59M	34.38M	39.06M	17.57M	14.42M	14.17M
Retained Earnings	-90.83M	-95.91M	-103.20M	-106.74M	-111.56M	-117.57M	-122.45M	-127.59M	-132.63M	-137.45M	-141.22M	-143.62M	-144.28M	-144.69M	-145.15M	-146.23M	-147.53M	-171.08M	-171.17M	-170.72M

Purple Biotech PPBT Balance Sheet (2014-2026)

Purple Biotech Quarterly Balance Sheet

Create an account

Sign In

Reset Password